<DOC>
	<DOC>NCT02076568</DOC>
	<brief_summary>This study is a multi-center, randomized prospective trial with a 6-month follow up. A newly developed treatment and education module will be tested compared to a waiting-list control group. The module covers the topic "diabetes and partnership". Primary outcome variable is diabetes-specific empowerment regarding diabetes and partnership. Secondary outcome variables are: diabetes-related distress, health-related quality of life, depressive symptoms, self-care behavior, and glycemic control.</brief_summary>
	<brief_title>Diabetes and Partnership: Evaluation of a Diabetes Education Module</brief_title>
	<detailed_description>The module consists of one lesson (duration: 90 minutes). The module is derived from the empowerment approach and is based on the previously evaluated education and treatment program for type 1 diabetes: PRIMAS (NCT01220557). The module is designed as a group session held by a trained diabetes educator. Patients are randomized either to the immediate participation in the module or to the control group. Control group is a waiting-list control group. Patients in this waiting-list control group get the education after the completion of the 6-month follow-up.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Intensive insulin treatment specific interest in "Diabetes and Partnership" wish to participate in group education informed consent fluent in reading and speaking German language diabetes duration &lt; 4 week severe organic disease (e.g. terminal renal disease, cancer with poor prognosis) current treatment of a mental disease cognitive impairment dementia pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>diabetes</keyword>
	<keyword>education</keyword>
	<keyword>randomized</keyword>
	<keyword>prospective</keyword>
</DOC>